Research Articles | Page 9 | Aplastic Anemia & MDS International Foundation Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Can iron overload in patients with lower-risk myelodysplastic syndromes be reduced using erythropoiesis-stimulating agents? Oct 2015 Ann Hematol myelodysplastic syndromes (MDS)
Prognostic pre-transplant factors in myelodysplastic syndromes primarily treated by high dose allogeneic hematopoietic stem cell transplantation: a retrospective study of the MDS subcommittee of the CMWP of the EBMT Sep 2016 Ann Hematol myelodysplastic syndromes (MDS)
The clinical importance of moderate/severe bone marrow fibrosis in patients with therapy-related myelodysplastic syndromes. May 2013 Ann Hematol myelodysplastic syndromes (MDS)
Application of the revised International Prognostic Scoring System for myelodysplastic syndromes in Argentinean patients Jul 2013 Ann Hematol myelodysplastic syndromes (MDS)
Centrosome aberrations in bone marrow cells from patients with myelodysplastic syndromes correlate with chromosomal instability. May 2013 Ann Hematol myelodysplastic syndromes (MDS)
Biosimilar epoetin in elderly patients with low-risk myelodysplastic syndromes improves anemia, quality of life, and brain function Apr 2014 Ann Hematol myelodysplastic syndromes (MDS)
Development of a disease-specific quality of life questionnaire for patients with aplastic anemia and/or paroxysmal nocturnal hemoglobinuria (QLQ-AA/PNH)-report on phases I and II Nov 2016 Ann Hematol paroxysmal nocturnal hemoglobinuria (PNH)
Multiparameter FLAER-based flow cytometry for screening of paroxysmal nocturnal hemoglobinuria enhances detection rates in patients with aplastic anemia Dec 2014 Ann Hematol aplastic anemia
Serologic response to meningococcal vaccination in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with the terminal complement inhibitor eculizumab Jan 2017 Ann Hematol paroxysmal nocturnal hemoglobinuria (PNH)
Prognostic impact of the number of methylated genes in myelodysplastic syndromes and acute myeloid leukemias treated with azacytidine. Jun 2013 Ann Hematol myelodysplastic syndromes (MDS)
Share with addtoany.com.